The thyroid ablation device market will gain $1,294.43 million by 2030, at a CAGR of 10.6%

The thyroid ablation device market will gain ,294.43 million by 2030, at a CAGR of 10.6%

world growth thyroid ablation device market it is mainly due to the increased prevalence of thyroid cancer and thyroid nodules; increased demand for minimally invasive surgeries; and increased availability of new technologically advanced products for thyroid ablation. Therefore, these aforementioned factors increase the use of thyroid ablation, driving the growth of the thyroid ablation device market. According to the American Cancer Society (ACS) publications, Cancer Facts & Figures 2021 and Cancer Facts & Figures 2020, approximately 44,280 adults (12,150 men and 32,130 women) in the US have been diagnosed with thyroid cancer .

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐑𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞-𝐂𝐎𝐕𝐈𝐃-19 𝐈𝐦𝐩𝐚𝐜𝐭 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐰𝐢𝐭𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐚𝐭 𝐚𝐭:

Key players operating in the global Thyroid Ablation Devices market include Boston Scientific Corporation, BVM Medical System, Integra LifeSciences, Johnson & Johnson, Medtronic Plc, Medwaves Inc., Olympus Corporation, STARmed Co., Ltd., Terumo Corporation, and Theraclion.

Thyroid cancer is the seventh most common cancer in women. Due to the increasing burden of thyroid cancer, the number of ablation surgeries is increasing. Furthermore, thyroid nodules are also on the rise as they are one of the most common diseases of the endocrine system. These aforementioned factors have led to an increase in the use of thyroid ablation in the treatment of cancer and thyroid nodules and are expected to drive the growth of the thyroid ablation device market in the near future. Additionally, advanced ablation technology is expected to drive the growth of the thyroid ablation device market during the forecast period.

Thyroid ablation devices are primarily used for the treatment of thyroid cancer and thyroid nodules. A thyroid nodule is an unusual growth (lump) of thyroid cells in the thyroid gland. Thyroid cancer is a solid tumor cancer that usually appears as a nodule or mass in the thyroid gland, which is located at the front base of the throat. It occurs when rogue cells reproduce too quickly for the immune system to control them. There are several types of thyroid cancer, but two types, papillary thyroid cancer and follicular thyroid cancer, are by far the most common, accounting for about 95 percent of cases.

The ablation technique is used to treat tumors and nodules in a minimally invasive way to reduce the size of thyroid nodules and restore thyroid function. Radiofrequency ablation (RFA) is a minimally invasive technique performed by an endocrine surgeon guided by ultrasound images. The doctor sends targeted radio waves that disrupt the cells in the nodule, causing them to shrink as the removed tissue is absorbed by the body. RFA also allows patients to resume normal daily activity with minimal recovery time. Although surgery may involve removing part of the thyroid, RFA maintains the integrity of the thyroid, which supports improved thyroid function.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭:

Highlights of the Thyroid Ablation Devices market report:

aspects Details
By type
  • Image Guided Ablation
  • radiofrequency ablation
  • microwave ablation
  • Others
per application
  • Thyroid cancer
  • thyroid nodules
By Distribution Channel
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Cancer Specialty Centers
  • Others
By region
  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Pacific Asia (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA (Latin America, Middle East and Africa)
By key market players
  • Boston Scientific Corporation
  • BVM Medical System
  • Integrative life sciences
  • Johnson and Johnson
  • medtronic plc
  • Medwaves Inc.
  • Olympus Corporation
  • STARmed Co. Ltd.
  • Terumo Corporation
  • Theraclion


Leave a Comment